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Summary: Elevated concentrations of atrial natriuretic peptide reportedly mitigate acute renal failure in vivo
and in the isolated perfused kidney (M. Nakamoto, J. L Shapiro, P. F. Shanley, L. Chan & R. W. Shrier (1987)
J. Clin. Invest. 50, 698-705; S. G. Shaw, J. Weidmann, J. Hodler, A. Zimmermann & A. Paternostro (1987)
J. Clin. Invest. 50, 1232 — 1237). Since atrial natriuretic peptide has been shown to be a potent vasodilator,
this beneficial effect may be due entirely to improved haemodynamics. To determine whether atrial natriuretic
peptide also has a protective effect at the cellular level, rat hepatocyte cell cultures were treated with atrial
natriuretic peptide prior to or after induction of cell damage by hypoxia (0.5% O2 for 4 h) or reactive oxygen
(hypochlorous acid). Bleb formation, degradation of radiolabeled trichloroacetic acid-precipitable peptides,
release of lactate dehydrogenase and trypan blue exclusion were used äs indicators of cell damage. Atrial
natriuretic peptide treatment distinctly protected the cell cultures against damage in both cases. This beneficial
effect of atrial natriuretic peptide was partly mimicked by sodium nitroprusside, which, like atrial natriuretic
peptide, largely increased the cellular cGMP content. 6-Anilino-5,8-quinolinedione (Ly 83583), an inhibitor
of particulate guanylate cyclase, blocked the protective effect of atrial natriuretic peptide. Therefore a cGMP-
mediated mechanism seems to be involved in the cytoprotective action of atrial natriuretic peptide. Fluoro-
metric measurements using the Ca2+-sensitive dye Quin-2 showed that the elevation of intracellular Ca2"1" after
cellular insult by hypochlorous acid is prevented by atrial natriuretic peptide. These results suggest that atrial
natriuretic peptide may attenuate hypoxic and toxic cell damage by increasing cGMP and reducing intracellular
Ca2+.
Introduction More recent reports have shown that elevated con-
Atrial nätriüfetic peptide, a hormone secreted from centrations of atrial natriuretic peptide can mitigate
specific granules of the mammalian atria (l, 2), ex- post-ischaemic renal failure in vivo and in the isolated
hibits several biological effects including vasorelaxa- perfused kidney (9, 10). It is possible that this effect
tion (3), natriuresis (2, 4), and Inhibition of aldoster* is mediated entirely by increased vasodilatation and
one-secretion (5). Atrial natriuretic peptide opposes improved haemodynamics. The following study ex-
the vascular snaooth muscle contraction induced by amined whether atrial natriuretic peptide can also
e. g. angiotensin II, norepinephrine, histamine and protect cells or cell cultures after exposure to hypoxia
serotonin (6, 7). Also, it has been shown that atrial and reactive oxygen (via hypochlorous acid), proce-
natriuretic peptide binds to specific receptors in the düres well known to induce cell damage similar to
vascular tissue (8). Therefore atrial natriuretic peptide post-ischaemic injury in vivo. Rat hepatocy tes were
may play an important physiologieal role in circula- used, and these showed a considerable increase in
tory homeostasis and haemodynamics. cGMP content after atrial natriuretic pepüde stimu-
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lation, suggesting the presence of atrial natriuretic
peptide receptors. Cell damage in hepatocytes was
assessed by the increased Formation of membrane
extrusions (blebs), the increased degradation of ra-
diolabeled polypeptides, the release of lactate dehy-
drogenase and the uptake of trypan blue, äs described
previously (11 — 13). Changes in intracellular free
Ca2+, which may play a central role in toxic and
ischaemic cell injury (14), were monitored using the
Ca2+-sensitive fluorescent dye, Quin-2. Our study
demonstrates that the beneficial effect of atrial natri-
uretic peptide observed after ischaemia and hypoxia
in the kidney may also be due to protective effects of
atrial natriuretic peptide at the cellular level.
Materials and Methods
Materials
Atrial natriuretic peptide, hypochlorous acid, sodium nitro-
prusside and Quin-2 (2-{[2-bis-(carboxymethyl)-amino-5-meth-
ylphenoxy]-methyl}-6-methoxy-8-bis-(carboxymethyl)-amino-
quinoline) tetraacetoxymethyl ester were from Sigma Chemi-
cals, Munich. Harris F-12 medium, Hanks" balanced salt so-
lution, Dulbecco's modifled Eagle's medium and collagenase
type II were from Seromed, Munich. All other solvents and
chemicals were from Merck, Dannstadt. 6-Anilino-5,8-quino-
linedione (Ly 83583) was a generous gift from Lilly Research
Laboratories, Indianapolis, Ind.
Cell cultures
Hepatocytes were isolated from fed male Sprague-Dawley rats,
weighing 150—200 g, by in situ perfusion of collagenase essen-
tially äs described previously (12). Yields of 0.2—0.4 · l O9 cells
per liver with 85—95% viability äs determined by trypan blue
exclusion, were routinely obtained. The hepatocytes were plated
at a density of 50 000/cm2 in collagen-coated petri^penn dishes
(Heraeus, DüsseldorO, containing Harris F-12 medium with
foetal calf serum (volume fraction 0.10) at 37 °C in a humified
atmosphere of 0.95 air and 0.05 CO2 for 6 h. After incubation
of cells for 6 h, the cells were washed with phosphate-buffered
saline to remove the unattached dead cells. Harris F-12 medium
supplemented with foetal calf serum (volume fraction 0.05) was
replaced and the cells were incubated for further 20 h.
Hypoxia experiments
Experiments were initiated after the 20 h-old plated cells had
been washed with phosphate-buffered saline and incubated in
Harris F-12 medium supplemented with foetal calf serum (vol-
ume fraction 0.05) for 2h. The hepatocyte monolayers were
divided into a 20%-O2 and a 0.5%-O2 (hypoxic) group. The
20%-O2 group was placed in a Standard incubator with 0.05
CO2:0.95 air at 37 °C. The hypoxic group was incubated at
37 °C in 0.005 O2:0.05 CO2:0.945 N2. An oxygen electrode
(Yellow Springs Instruments) was immersed in the medium of
a culture dish to monitor O2 concentration. Usually 80—90
min were required for equilibration of the O2 concentration in
the medium with the desired gas phase concentration. During
hypoxia, atrial natriuretic peptide and other drugs (in saline-
stock Solutions equilibrated with the hypoxic gas) were added
via an airlock. Viability of the eultured cells was assayed by
trypan blue exclusion and release of lactate dehydrogenase,
essentially äs described by Rubin & Farber (13). The amount
of enzyme in the supernatant was defined äs the percentage of
total enzyme released after exposure of the cells to digitonin
(2 g/l) for 30 min.
Treatment of hepatocytes with HC1O
In experiments with HC1O the 20 h-old plated cells were washed
with a modified Krebs-Henseleit buffer containing dialysed bo-
vine serum albumin (20 g/l), glucose (15 mmol/1), Hepes (20
mmol/l), pH 7.4 and incubated in the same buffer at 37 °C
under an atmosphere of 0.95 O2, 0.05 CO2 for 2 h without
further additions. The plated hepatocytes were then checked
by microscopy and trypan blue exclusion to ensure viability.
HC1O (0.1 mmol/1) was added to intact cultures äs indicated
without further changes of the medium. Readjustment of the
pH after addition of HC1O was not necessary. Controls con-
tained the appropriate solvents without HC1O. All assays were
done in triplicate.
cGMP/cAMP determinations
Isolated hepatocytes (l 109/1) were washed twice with Dul·
beccö's modified Eagles medium and then preincubated in
culture dishes for 15 min in Dulbecco*s modified Eagle's medium
containing 10 mmol/l Hepes (pH 7.3) and 0.5 mmol/1 isobutyl-
methylxanthine at 37 °C (0.05 CQ2, 0.95 air). Atrial natriuretic
peptide and/or other drugs were added to the cells for various
times äs indicated. After rapid centrifugation, the medium was
aspirated, and 0.75—1 ml of ice^cold trichloroacetic acid (60
g/l) was added to the cells. The intracellular cGMP and cAMP
content was then measured by commercially available radioim-
munoassay kits (New England Nuclear, Dreieich) äs described
(15).
Bleb formation, proteolysis of cellular polypeptides
In some experiments cell damage was also assessed by deter-
mining the percentage increase of membrane blebs äs described
previously (11). The rate of intracellular proteolysis was meas-
ured by the method of Seglen et al. (16) äs modified by von
Ruecker et al. (12).
Measurement of cytosolic free Ca2+ concentration
Isolated hepatocytes were incubated with Quhv2 tetraacetoxy-
methyl ester (Quin-2/AM) essentially äs described by Nicchitta
et al. (17). Briefly, cells were incubated at a concentration of
3 109/l in modified Hank9s medium supplemented with 20 g/l
dialysed bovine serum albumin, and Quin-2/AM was added to
a final concentration of 50 umol/1. After loading of hepatoey tes
for 15 min, the cells were washed twice in modified Hank's
buffer, containing l mmol/1 CaCl2 and l mmol/1 MgCl2. The
cells were then resuspended in the same buffer at a cell concen-
tration of l 109/1, and the fluorescence was recorded before
and after HClO-treatment in a Perkin Eimer LS-5 spectroftuo-
rometer. The excitation wavelength was 339 nm and the eniis-
sion was recorded at 500 nm using a cutoff filter. The cuvette
chämber was kept at 37 °C arid the cells were continuously
stirred under an atmosphere of 0.95 O2, 0.05 CO2. Values for
intracellular free Ca2+ were estimated by the method of Tsien
et al. (18).
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Results and Discussion
Effect of atrial natriuretic peptide and dif-
ferent drugs on cGMP/cAMP accumulation
in hepatocytes
The increase in cellular cGMP content at different
atrial natriuretic peptide concentrations in hepato-
cytes is shown in figure l. At optimal concentrations
(^0.1 μιηοΐ/ΐ), atrial natriuretic peptide caused a 12—
15-fold increase in cellular cGMP. Table l shows that
atrial natriuretic peptide did not alter the cellular
cAMP content of hepatocytes, in contrast to the effect
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Fig. l Cyclic-GMP production of hepatocytes in response to
increasing concentrations of atrial natriuretic peptide.
Hepatocytes were prepared and incubated at 37 °C for
10 min in the absence and presence of atrial natriuretic
peptide s described in Methods. The cGMP levels in
the cells were measured by radioimmunoassay (15).
Values represent the mean ± S. E. of 5 separate exper-
iments, each perfprmed in triplicate.
0 = withomt atrial natriuretic peptide
prusside (10 μιηοΐ/ΐ) also strongly increased the cel-
lular cGMP content without changing cellular cAMP
concentrations. The effects of atrial natriuretic pep-
tide and nitroprusside on cellular cGMP were nearly
additive (tab. 1). This confirms observations in rat
lung fibroblasts made by Leitman et al. (15), who
suggested that atrial natriuretic peptide and nitro-
prusside increase different pools of cGMP by acti-
vating different isoenzyme forms of guanylate cyclase.
The drug 6-anilino-5,8-quinolinedione (Ly 83583),
which interferes with the activation of the particulate
guanylate cyclase (20), completely abolished the atrial
natriuretic peptide-induced increase in cellular cGMP
(tab. 1). These results suggest that hepatocytes possess
receptors for atrial natriuretic peptide, and that the
binding of atrial natriuretic peptide to the receptor
on the hepatocyte membrane stimulates the particu-
late guanylate cyclase. Others have reported (21) that
atrial natriuretic peptide activates the guanylate cy-
clase in particulate fractions from homogenates of rat
liver.
Protective effect of atrial natriuretic peptide
on hepatocyte monolayers exposed to hyp-
oxia and reoxygenation
Hepatocyte monolayers were exposed to 0.5% oxygen
for 4 h; this low oxygen concentration has been shown
to cause hypoxic injury in hepatocytes after reoxy-
genation (22). Figure 2 shows that with no reoxygen-
ation period after hypoxia, the cells remained viable
s judged by trypan blue exclusion. Also, the release
of lactate dehydrogenase from the hypoxic cells into
the supernatant was not notably increased compared
with controls (fig. 2b). Atrial natriuretic peptide
(l μτηοΐ/ΐ), given at the indicated intervals during hyp-
oxia, and the inhibitpr von 6-anilino-5,8-quinoline-
dione (Ly 83583) (10 μιηοΐ/ΐ) did not change the
outcome of the 0 h-reoxygenation experiment. On the
other hand, if the cells were exposed to prolonged
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Isolated hepatocytes were incubated at 37 °C for 10 min in the presence of either atrial natriuretic peptide, sodium nitroprusside
or the combination of both agents, s described in Methods. 6-Anilino-5,8-quinolinedione (Ly 83583) was added 5 min prior to
addition of atrial natriuretic peptide. The intracellular cGMP and cAMP levels were measured by radioimmunoassay s described
(15). Each value represents the mean ± S.E. from 7 different experiments performed in triplicate.
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Fig. 2. Cytoprotective action of atrial natriuretic peptide after hypoxia and reoxygenation in cultured hepatocytes. Hepatocyte
cell cultures were exposed to hypoxia (0.5% O2) for 4 h and reoxygenation (20% O2) for 0 and 20 h s described in
Methode. Atrial natriuretic peptide (l μιηοΐ/ΐ) was added to the cell cultures immediately prior to hypoxia, after 2 h of
hypoxia (via airlock) and at the end of hypoxia s indicated below. 6-Anilino-5,8-quinolinedione (Ly 83583) (10 μηιοΙ/1)
was added to the cuiture medium 1—2 min before atrial natriuretic peptide.
a) Cell survival assessed by trypan blue exclusion, and
b) Cell lysis assessed by release of lactate dehydrogenase into the supernatant.
Normoxic controls with drug additions did not dififer from controls withoiit drugs. Values are the mean ± S. E. of 3
separate experiments, each performed in triplicate.
control;
hypoxia 4 h without additions;
EXXXXXI hypoxia 4 h in the presence of atrial natriuretic peptide;
hypoxia 4 h in the presence of atrial natriuretic peptide and 6-anilino-5,8-quinolinedione (Ly 83583);
hypoxia 4 h; atrial natriuretic peptide added after 2 h;
hypoxia 4 h; atrial natriuretic peptide added after 4 h.
* p < 0.01; ** p < 0.05; ns = not significant (in comparison with 4 h hypoxia treatment without additions).
20 h reoxygenation, the survival rate was low (trypan
blue exclusion was observed in less than 15% of the
cells) and most cells were lysed s judged by the release
of lactate dehydrogenase (fig. 2a and 2b). Atrial na-
triuretic peptide treatment, given before, during or
after hypoxia, distinctly increased the survival rate
and lessened cell lysis; atrial natriuretic peptide was
most effective when added before hypoxia, and the
beneficial effect was notably less when atrial natri-
uretic peptide was given after a 2 or 4h hypoxia
period. 6-Anilino-5,8-quinolinedione (Ly 83583),
which suppressed the atrial natriuretic peptide-me-
diated formation of cGMP (tab. 1), greatly diminished
the cytoprotective effect of atrial natriuretic peptide
(fig. 2). Therefore, a cGMP-dependent mechanism
seems to be involved in atrial natriuretic peptide-
induced cytoprotection.
In these experiments detectable d mage to the cells
occurred after the physiological oxygen concentration
had been restored, rather than during the hypoxic
period itself. This so-called 'reoxygenation effect' after
hypoxia has been observed by several authors in var-
ious tissues (for review see L c. (23)), and it has been
attributed to increased lipid peroxidation, by the re-
active oxygen that is formed after reoxygenation. Sim-
ilar reoxygenation effects in hepatocytes exposed to
hypoxia have been observed by Costa et al. (22).
Nevertheless, since atrial natriuretic peptide was more
beneficial when it was added earlier during hypoxia
(fig. 2), some irreversible detrimental events, even
though not detectable by the methods employed, seem
to occur during hypoxia.
Protective effect of atrial natriuretic peptide
after treatment of hepatocyte monolayers
with bypochlorous acid
Hypochlorous acid fonris reactiVe oxygen when ex-
posed to diffuse daylight (HC1O -> O + HC1). In
order to study the effects of reactive oxygen, whieh
is kn wn to dversely influence tissues during reoxy-
genation (23), we decided to apply HC1O to hepato-
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Fig. 3. Protection of cultured hepatocytes against HClO-induced cell damage by atrial natriuretic peptide. Hepatocyte cell cultures
were exposed to HC1O (0.1 mmol/1) for 30 min in the absence and presence of atrial natriuretic peptide (l μπιοΐ/ΐ), sodium
nitroprusside (10 μηιοΐ/ΐ) and 6-anilino-5,8-quinolinedione (Ly 83583) (10 μιηοΐ/ΐ) s indicated below. The drugs or
combination of drugs were added 5 min prior to HC1O. Cell damage was assessed (see Methods) by
a) bleb formation (control: 5.2% of 3 χ 500 cells with blebs),
b) trypan blue uptake (control: 2,7% of 3 χ 500 cells with dye uptake),
c) lactate dehydrogenase in supernatant (control: 1.8% of maximal release in supernatant),
d) proteolysis of [14C]valine-labeled cellular proteins (control: 3.1% of [I4C]valine-incorporation was trichloroacetic acid-
soluble).
Control experiments done in the absence of HC1O but in the presence of atrial natriuretic peptide, sodium nitroprusside
and 6-anilino-5,8-quinolinedione (Ly 83583) did not significantly differ from normal control experiments without drugs.
Values are the rnean ± S. E. of 3 separate experiments, each performed in triplicate.
J control cells;
] cells treated with HCIO;
cells treated with HCIO in the presence of atrial natriuretic peptide;
cells treated with HCIO in the presence of atrial natriuretic peptide and 6-anilino-5,8-quinolinedione (Ly 83583);
cells treated with HCIO in the presence of Na* nitroprusside.
p < 0.01; ** p < 0.05; ns = not significant (in comparison with cells treated with HCIO).
cyte monolayers. Again atrial natriuretic peptide was
used in HClO-treated monolayers to determine its
Potential s a cytoprotective agent. Nitroprusside,
which like atrial natriuretic peptide, increased the
cellular cGMP content of hepatocytes (but via soluble
guanylate cyclase) (tab. 1), was also tested. Fig re 3
shows that all indicators of the onset of cell damage
(i.e. bleb formation, trypan blue uptake, release of
lactate dehydrogenase, increase in proteolysis) were
distinctly increased if the cells were treated with HCIO
(0.1 mmol/1) for 30 min at 37 °C. Pretreatment of
cells with atrial natriuretic peptide (l μπιοΐ/ΐ) or ni-
troprusside (10 μηιοΐ/ΐ) nearly abolished the cell-d m-
aging effects of HC1Q (0.1 mrn l/1). 6-Anilino-5,8-
quinolinedione (Ly 83583) (10 μιροΐ/ΐ), which blocks
atrial natriuretic peptide-dnduced activation of the
particulate guanylate cyclase, largely inhibited the
protective action of atrial natriuretic peptide (fig. 3).
Controls done in the presence of these drugs but
without HCIO did not differ from normal controls
(data not shown). These observations suggest that, s
in the case of hypoxic cell injury (fig. 2), atrial natri-
uretic peptide also induces cytoprotective action after
cellular insult by HCIO (or reactive oxygen). A
cGMP-dependent mechanism seems to be involved.
Increase of intracellular Ca2"1" following cell
damage by hypochlorous acid and its preven-
tion by atrial natriuretic peptide and sodium
nitroprusside
Various authors stress that alterations in cellular Ca2+
homeostasis may be the critical event in hypoxic and
reactive oxygen-induced cell injury (for review see 1. c.
(14)). Since smooth muscle cells have been shown to
loose Ca2+ s a consequence of cGMP accumulation
(24) and atrial natriuretic peptide treatment (25), we
examined whether atrial natriuretic peptide and nitro-
prusside influenee the intracellular free Ca2+ concen-
tration of hepatocytes following exposure to HCIO.
Fig re 4 shows that a slow but distinct increase in
cytosolic free Ca2"1" occurred in HClO-treated hepa-
tocytes for at least 10 min. This increase in intracell-
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ular Ca2+ was inhibited by atrial natriuretic peptide
(fig. 4) and nitroprusside (data not shown) in a similar
fashion. 6-Anilino-5,8-quinolinedione (Ly 83583)
blocked the action of atrial natriuretic peptide on
intracellular Ca2+. In the absence of HC1O, atrial
natriuretic peptide and nitroprusside caused only a
small decrease (< 10%) of cytosolic Ca2+ dufing the
observation period. These findings lead us to propose
Incubation time Cminl
Fig. 4. Inhibition of HClO-induced increase in cytosolic free
Ca2+ in hepatocytes by atrial natriuretic peptide. Iso-
lated hepatocytes were loaded with Quin-2 and incu-
bated at 37 °C in an spectrofluorometer s described in
Methods. Fluorescence was measured once or twice per
min. After stabilization of the Quin-2 signal (approx.
2 min), a solvent with or without atrial natriuretic pep-
tide (l μιηοΐ/ΐ) was added l min prior to the addition
of HC1O (0.1 mmol/1). Cytosolic Ca2+ levels were de-
termined s described by Tsien et al. (18). Bach point
represents the mean ± S. E. of 4 experiments.
control cells;
cells treated with HC1O;
cells treated with HC1O in the presence of
atrial natriuretic peptide;
cells treated with HC1O in the presence of
atrial natriuretic peptide + 6-anilino-5,8-
quinolinedione (Ly 83583)
D α
that atrial natriuretic peptide and nitroprusside pro-
tect hepatocytes against HClO-induced cell injury by
preventing the post-injury increases of intracellular
Ca2+.
Concluding Remarks
Our results show that atrial natrijufetic peptide can
protect hepatocytes after hypoxic and toxic (HC1O)
insult. The beneficial effects of elevated atrial natri-
uretic peptide concentrations observed in acute is-
chaemic renal failure (9) and in the isolated perfused
kidney (10) may therefore not only be due to atrial
natriuretic peptide-induced vasodilatation and im-
proved haemodynamics, but also to atrial natriuretic
peptide-induced protection at the cellular level. The
cytoprotective actipns of atrial natriuretic peptide
were mimicked in our experiments by nitroprusside,
which, like atrial natriuretic peptide, increases the
cGMP content in the cell. 6-Anilino-5,8-quinoline^
dione (Ly 83583), which inhibits activation of the
particulate guanylate cyclase by atrial natriuretic pep-
tide, largely blocked the protective effect f atrial
natriuretic peptide. Therefore the Formation of cGMP
and cGMP-dependent mechanisms seem important
for cytoprotectioii by atrial natriuretic peptide. Since
HClO-induced cell injury and the accompanying in-
crease in intracellular Ca2+ were simultaneously pre-
vented by atrial natriuretic peptide, it is reasonable
to assume that the cytoprotective effects of atrial
natriuretic peptide are mediated by Systems involved
in the maintenance of cellular Ca2+ balance. Via
cGMP-dependent mechanisms, atrial natriuretic pep-
tide may be involved in the modulation of the gating
of voltager-dependent Ca2+ channels (26), or in the
modulation of the Ca2+-pumping ATPase and the
Na^/Ca2·*· exchange System present in the cell mem-
brane (27, 28). The exact mechanism of atrial natri-
uretic peptide remains to be elucidated.
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